Literature DB >> 9708241

Cross infection between cystic fibrosis patients colonised with Burkholderia cepacia.

M J Ledson1, M J Gallagher, J E Corkill, C A Hart, M J Walshaw.   

Abstract

Whilst patient to patient spread of the respiratory pathogen Burkholderia cepacia is well recognised between patients with cystic fibrosis, prompting a strict segregation policy, cross colonisation between cystic fibrosis patients already infected with B cepacia has not been described and surveys show a very low incidence of patients with more than one strain. Five adult cystic fibrosis patients with B cepacia are presented who became cross colonised with a second B cepacia (UK epidemic) strain, four of whom then died, three from the cepacia syndrome. These cases show that, amongst segregated patients, cross colonisation with different B cepacia strains is possible, and even in these patients the acquisition of the UK epidemic strain may have a fatal outcome. In future it may be necessary to segregate cystic fibrosis patients colonised with the UK epidemic strain from all other patients with cystic fibrosis.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9708241      PMCID: PMC1745231          DOI: 10.1136/thx.53.5.432

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  32 in total

1.  Pseudomonas and all that.

Authors:  C A Hart; C Winstanley
Journal:  Arch Dis Child       Date:  1999-07       Impact factor: 3.791

2.  Pulsed-field gel electrophoresis of degradation-sensitive DNAs from Clostridium difficile PCR ribotype 1 strains.

Authors:  J E Corkill; R Graham; C A Hart; S Stubbs
Journal:  J Clin Microbiol       Date:  2000-07       Impact factor: 5.948

Review 3.  Infection control in cystic fibrosis: methicillin-resistant Staphylococcus aureus, Pseudomonas aeruginosa and the Burkholderia cepacia complex.

Authors:  J R Govan
Journal:  J R Soc Med       Date:  2000       Impact factor: 5.344

Review 4.  Recent advances in cross-infection in cystic fibrosis: Burkholderia cepacia complex, Pseudomonas aeruginosa, MRSA and Pandoraea spp.

Authors:  Andrew M Jones; A Kevin Webb
Journal:  J R Soc Med       Date:  2003       Impact factor: 5.344

5.  Enhanced susceptibility to pulmonary infection with Burkholderia cepacia in Cftr(-/-) mice.

Authors:  U Sajjan; G Thanassoulis; V Cherapanov; A Lu; C Sjolin; B Steer; Y J Wu; O D Rotstein; G Kent; C McKerlie; J Forstner; G P Downey
Journal:  Infect Immun       Date:  2001-08       Impact factor: 3.441

6.  Segregation is good for patients with cystic fibrosis.

Authors:  Steven Conway
Journal:  J R Soc Med       Date:  2008-07       Impact factor: 5.344

7.  Outcome of Burkholderia cepacia colonisation in an adult cystic fibrosis centre.

Authors:  M J Ledson; M J Gallagher; M Jackson; C A Hart; M J Walshaw
Journal:  Thorax       Date:  2002-02       Impact factor: 9.139

8.  High relatedness selects against hypermutability in bacterial metapopulations.

Authors:  Freya Harrison; Angus Buckling
Journal:  Proc Biol Sci       Date:  2007-05-22       Impact factor: 5.349

Review 9.  The changing microbial epidemiology in cystic fibrosis.

Authors:  John J Lipuma
Journal:  Clin Microbiol Rev       Date:  2010-04       Impact factor: 26.132

Review 10.  Infection control in cystic fibrosis.

Authors:  Lisa Saiman; Jane Siegel
Journal:  Clin Microbiol Rev       Date:  2004-01       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.